We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Cryo-EM Reveals How Malaria Parasites Invade Blood Cells

By LabMedica International staff writers
Posted on 09 Jul 2018
Results of cryo-electron microscopy (cryo-EM) studies revealed the molecular mechanism by which the Plasmodium vivax malaria parasite binds to and invades red blood cells in the human host.

Plasmodium vivax is a protozoal parasite and a human pathogen. More...
This parasite is the most frequent and widely distributed cause of recurring malaria. P. vivax is one of the five species of malaria parasites that commonly infect humans. Although it is less virulent than Plasmodium falciparum, the deadliest of the five human malaria parasites, P. vivax malaria infections can lead to severe disease and death. P. vivax is believed to have originated in Asia and is found mainly in Asia and Latin America – where it accounts for 65% of malaria cases - and in some parts of Africa. However, latest studies have shown that wild chimpanzees and gorillas throughout central Africa are endemically infected with parasites that are closely related to human P. vivax, findings that indicate that human P. vivax is actually of African origin.

Cryo-EM is an analytical technique that provides near-atomic structural resolution without requirements for crystallization or limits on molecular size and complexity imposed by the other techniques. Cryo-EM allows the observation of specimens that have not been stained or fixed in any way, showing them in their native environment while integrating multiple images to form a three-dimensional model of the sample.

Prior studies indicated that P. vivax used the human transferrin receptor 1 (TfR1) to gain access to red blood cells. TfR1-deficient erythroid cells were refractory to invasion by P. vivax, and anti-PvRBP2b (P. vivax reticulocyte-binding protein 2b) monoclonal antibodies inhibited reticulocyte binding and blocked P. vivax invasion in field isolates.

In a follow-up study, investigators at the Walter and Eliza Hall Institute (Melbourne, Australia) utilized high-resolution cryo-EM to establish the structure of a complex of PvRBP2b bound to human TfR1 and transferrin.

The investigators reported in the June 27, 2018, online edition of the journal Nature that PvRBP2b residues involved in the complex formation were conserved, suggesting that antigens could be designed that would act across P. vivax strains. Functional analyses of TfR1 highlighted how P. vivax hijacked TfR1, an essential housekeeping protein, by binding to sites that govern host specificity, without affecting its cellular function of transporting iron.

"We have now mapped, down to the atomic level, exactly how the parasite interacts with the human transferrin receptor," said Dr. Wai-Hong Tham, a laboratory head in the division of infection and immunity at the Walter and Eliza Hall Institute. "This is critical for taking our original finding to the next stage - developing potential new antimalarial drugs and vaccines. Cryo-EM is really opening doors for researchers to visualize structures that were previously too large and complex to "solve" before."

"It is basically a design challenge. P. vivax parasites are incredibly diverse - which is challenging for vaccine development. We have now identified the molecular machinery that would be the best target for an antimalarial vaccine effective against the widest range of P. vivax parasites," said Dr. Tham. "With this unprecedented level of detail, we can now begin to design new therapies that specifically target and disrupt the parasite's invasion machinery, preventing malaria parasites from hijacking human red blood cells to spread through the blood and, ultimately, be transmitted to others."

Related Links:
Walter and Eliza Hall Institute


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Biochemical Analyzer
iBC 900
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.